BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 32375354)

  • 1. Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases.
    Giudice V; Mensitieri F; Izzo V; Filippelli A; Selleri C
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
    Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA and RNA aptamers: from tools for basic research towards therapeutic applications.
    Ulrich H; Trujillo CA; Nery AA; Alves JM; Majumder P; Resende RR; Martins AH
    Comb Chem High Throughput Screen; 2006 Sep; 9(8):619-32. PubMed ID: 17017882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Specific Aptamers.
    Liu S; Suzuki Y; Inui M
    Methods Mol Biol; 2018; 1868():113-121. PubMed ID: 30244458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-SELEX optimization of aptamers.
    Gao S; Zheng X; Jiao B; Wang L
    Anal Bioanal Chem; 2016 Jul; 408(17):4567-73. PubMed ID: 27173394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advancements in complex target systematic evolution of ligands by exponential enrichment].
    Wu Z; Xue S; Yang Y
    Se Pu; 2018 Oct; 36(10):947-951. PubMed ID: 30378352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SELEX--a (r)evolutionary method to generate high-affinity nucleic acid ligands.
    Stoltenburg R; Reinemann C; Strehlitz B
    Biomol Eng; 2007 Oct; 24(4):381-403. PubMed ID: 17627883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Aptamers in clinical diagnostics].
    SzpechciƄski A; Grzanka A
    Postepy Biochem; 2006; 52(3):260-70. PubMed ID: 17201061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemically modified DNA aptamers bind interleukin-6 with high affinity and inhibit signaling by blocking its interaction with interleukin-6 receptor.
    Gupta S; Hirota M; Waugh SM; Murakami I; Suzuki T; Muraguchi M; Shibamori M; Ishikawa Y; Jarvis TC; Carter JD; Zhang C; Gawande B; Vrkljan M; Janjic N; Schneider DJ
    J Biol Chem; 2014 Mar; 289(12):8706-19. PubMed ID: 24415766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamers: multifunctional molecules for biomedical research.
    Banerjee J; Nilsen-Hamilton M
    J Mol Med (Berl); 2013 Dec; 91(12):1333-42. PubMed ID: 24045702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SELEX methods on the road to protein targeting with nucleic acid aptamers.
    Bayat P; Nosrati R; Alibolandi M; Rafatpanah H; Abnous K; Khedri M; Ramezani M
    Biochimie; 2018 Nov; 154():132-155. PubMed ID: 30193856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aptamers in hematological malignancies and their potential therapeutic implications.
    Ouyang W; Yu Z; Zhao X; Lu S; Wang Z
    Crit Rev Oncol Hematol; 2016 Oct; 106():108-17. PubMed ID: 27637356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selection and Application of Aptamers and Intramers.
    Avci-Adali M
    Adv Exp Med Biol; 2016; 917():241-58. PubMed ID: 27236559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel insights into the role of aptamers in the fight against cancer.
    Maimaitiyiming Y; Hong F; Yang C; Naranmandura H
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):797-810. PubMed ID: 30830295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA aptamers: a review of recent trends and applications.
    Kang KN; Lee YS
    Adv Biochem Eng Biotechnol; 2013; 131():153-69. PubMed ID: 22491855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SELEX Modifications and Bioanalytical Techniques for Aptamer-Target Binding Characterization.
    Tan SY; Acquah C; Sidhu A; Ongkudon CM; Yon LS; Danquah MK
    Crit Rev Anal Chem; 2016 Nov; 46(6):521-37. PubMed ID: 26980177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of Complex Target SELEX to Identify Aptamers against Mammalian Cell-Surface Antigens.
    Mallikaratchy P
    Molecules; 2017 Jan; 22(2):. PubMed ID: 28146093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Effects of SELEX Conditions on the Resultant Aptamer Pools in the Selection of Aptamers Binding to Bacterial Cells.
    Hamula CL; Peng H; Wang Z; Newbigging AM; Tyrrell GJ; Li XF; Le XC
    J Mol Evol; 2015 Dec; 81(5-6):194-209. PubMed ID: 26538121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-step stimulus-response cell-SELEX method to generate a DNA aptamer to recognize inflamed human aortic endothelial cells as a potential in vivo molecular probe for atherosclerosis plaque detection.
    Ji K; Lim WS; Li SF; Bhakoo K
    Anal Bioanal Chem; 2013 Aug; 405(21):6853-61. PubMed ID: 23842900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids.
    Macedo B; Cordeiro Y
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.